chemotherapy
FDA Issues Safety Alert Reminding Doctors to Discuss DPD Deficiency Risk With Cancer Patients
The FDA, which has stopped short of requiring DPYD testing for patients before receiving fluoropyrimidines, emphasized the importance of discussing it.
Doctors and patient advocates supporting pretreatment testing at times challenged FDA and other experts who aren't swayed by available evidence.
Foresight Diagnostics Launches Lymphoma Personalized Treatment Clinical Trial
The trial will study the use of Foresight's Clarity MRD assay in identifying early treatment responders for therapy de-escalation.
Investigators from Atrium Health recently published a study comparing pretreatment and posttreatment testing, showing a strong benefit in a real-world clinical cohort.
Saladax Gets Canadian Approval for Chemotherapy Monitoring Test
The test is designed to monitor levels of 5-fluorouracil, a widely used chemotherapeutic with a range of potential adverse effects.